Our team developed and tested our initial diagnostic platform, integrating cutting-edge biomarker analysis with user-friendly interfaces

We partnered with clinics and research institutions to validate our solutions in real-world settings, gathering vital feedback to refine our offerings

Carelis broadened its portfolio to include telehealth and personalized treatment planning, forging collaborations with top healthcare providers

With enhanced AI diagnostics and expanded membership options, Carelis is poised to empower even more patients and providers globally